[Pharmacokinetic profile of naftopidil in rats].
Naftopidil(Naf), a novel antihypertensive drug, was determined by HPLC-UV method. The plasma concentration and pharmacokinetics of naftopidil have been investigated in rats after single oral doses of 10, 20 and 30 mg.kg-1. The drug was found to conform to a two-compartment model. Tp was in the range of 0.42 h to 0.90 h. T1/2 beta was 7.08 h after the 10 mg.kg-1 dose, 4.78 h after the 20 mg.kg-1 dose and 5.83 h after the 30 mg.kg-1 dose. The Cmax, AUC and CL/F appeared to be dose dependent at the doses not higher than 20 mg.kg-1. Naf was found in many tissues after a single oral dose of 20 mg.kg-1. The top level tissues were intestine, liver and lung at 15 minutes after administration, while the utero-ovarian tissue was the highest at 6 h. Naf can be extensively metabolized since the total excretion of the parent compound in urine and faeces was less than 1% of the dose. From 82% to 97% of Naf in plasma was shown to be bound to protein.
Yu
D
D
Department of Pharmacology, Beijing Medical University, Beijing 100083.
Wan
L
L
Lou
Y
Y
D000818:Animals; D000959:Antihypertensive Agents / Q000493:pharmacokinetics*; D019540:Area Under Curve; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D005260:Female; D008297:Male; D009281:Naphthalenes / Q000493:pharmacokinetics*; D010879:Piperazines / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution
D000959:Antihypertensive Agents; D009281:Naphthalenes; D010879:Piperazines; C064357:naftopidil